Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | Pres, Global Ops & Qual | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,330 |
Reported balance
After 2026-06-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-18 · Sale · Disposed 3,670 · Balance 66,330 F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2: Includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
F2: Includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 20:14 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,670 | $9.38 | $34,424.60 |
DisclosureSEC source: 0001193125-26-277526 · ownership.xml · nonDerivative · entry 1 McPherron Aviva · CIK 0002067285 · Pres, Global Ops & Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,330 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 21:16 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,263 | $12.55 | $15,851.66 |
DisclosureSEC source: 0001193125-26-096568 · ownership.xml · nonDerivative · entry 2 McPherron Aviva · CIK 0002067285 · Pres, Global Ops & Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,853 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive. F3 · balance_after: Includes 54,692 previously reported restricted stock units. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:16 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,296 | $12.92 | $16,739.52 |
DisclosureSEC source: 0001193125-26-096568 · ownership.xml · nonDerivative · entry 1 McPherron Aviva · CIK 0002067285 · Pres, Global Ops & Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,116 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · balance_after: Includes 54,692 previously reported restricted stock units. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:51 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 54,656 | $0.00 Strike: $13.03 | $0.00 |
DisclosureSEC source: 0001193125-26-094477 · ownership.xml · derivative · entry 2 McPherron Aviva · CIK 0002067285 · Pres, Global Ops & Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,656 Underlying: Common Stock · 54,656 shares Expires 2033-03-03 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:51 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 23,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-094477 · ownership.xml · nonDerivative · entry 1 McPherron Aviva · CIK 0002067285 · Pres, Global Ops & Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,412 F1 · shares: Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date. F2 · balance_after: Includes 37,557 previously reported restricted stock units and 1,066 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:15 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,728 | $10.51 | $39,181.28 |
DisclosureSEC source: 0000950170-25-088987 · ownership.xml · nonDerivative · entry 1 McPherron Aviva · CIK 0002067285 · Pres, Global Ops & Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,322 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 37,557 previously reported restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.